Provided by Tiger Trade Technology Pte. Ltd.

Cardinal Health

206.31
-0.2700-0.13%
Pre-market: 208.211.90+0.92%08:15 EDT
Volume:1.51M
Turnover:313.10M
Market Cap:48.55B
PE:29.71
High:209.96
Open:209.10
Low:205.71
Close:206.58
52wk High:233.60
52wk Low:120.72
Shares:235.32M
Float Shares:235.32M
Volume Ratio:0.81
T/O Rate:0.64%
Dividend:2.04
Dividend Rate:0.99%
EPS(TTM):6.94
EPS(LYR):6.48
ROE:-171.32%
ROA:3.50%
PB:-16.83
PE(LYR):31.85

Loading ...

Drug Distributors Poised for Growth Amid Emerging Risks, BofA Says

MT Newswires Live
·
Jan 06

Crinetics Experimental Pill Slashes Hormones In Rare Adrenal Disease Trial

Benzinga_recent_news
·
Jan 06

Crinetics Announces Strong PALSONIFY Launch Execution and Positive Results for Concurrent Androstenedione Lowering and Glucocorticoid Dose Reduction in Phase 2 Trial of Atumelnant for Congenital Adrenal Hyperplasia

GlobeNewswire
·
Jan 05

These Healthcare and Bank Stocks Had Incredible Runs in 2025. Why Gains Will Continue This Year. -- Barrons.com

Dow Jones
·
Jan 03

Best Income Ideas for 2026: Dividend Stocks, Energy Pipelines, and Other Top Picks

Dow Jones
·
Jan 02

Cardinal Health Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Dec 23, 2025

Cardinal Health Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Dec 20, 2025

BREAKINGVIEWS-Medline IPO girded by vast US healthcare complex

Reuters
·
Dec 17, 2025

Jim Cramer: Sell This Major Energy Stock, Go With This Canadian Mining Company

Benzinga_recent_news
·
Dec 16, 2025

Crinetics Announces First Patient Dosed in Pivotal Adult Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH)

GlobeNewswire
·
Dec 12, 2025

Cardinal Health Initiated at Overweight by Barclays

Dow Jones
·
Dec 09, 2025

U.S. RESEARCH ROUNDUP-AstraZeneca, Confluent, Pepsico

Reuters
·
Dec 09, 2025

Cardinal Health Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Dec 02, 2025

Cardinal Health Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Nov 26, 2025

6 Healthcare Stocks With Strong Upward Momentum

Benzinga_recent_news
·
Nov 19, 2025

Deutsche Bank Raises Price Target on Cardinal Health to $208 From $195, Keeps Hold Rating

MT Newswires Live
·
Nov 18, 2025

Cardinal Health (CAH): Is the Stock's Strong Momentum Fully Priced In? A Fresh Look at Valuation

Simply Wall St.
·
Nov 18, 2025

Leerink Partners Adjusts PT on Cardinal Health to $230 From $211, Maintains Outperform Rating

MT Newswires Live
·
Nov 17, 2025

Cardinal Health Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Nov 08, 2025

Cardinal Health price target raised to $224 from $190 at Morgan Stanley

TIPRANKS
·
Nov 08, 2025